Article
Publicly Available
In this issue
Published/Copyright:
April 8, 2015
Published Online: 2015-4-8
Published in Print: 2015-4-1
©2015 by De Gruyter
Articles in the same Issue
- Frontmatter
- In this issue
- Guest Editorial
- Nanomedicines: are we lost in translation?
- Meeting Report
- Is the translational approach becoming a reality in nanomedicine?
- Review
- Designer peptide delivery systems for gene therapy
- Original Articles
- Combined silencing expression of MGMT with EGFR or galectin-1 enhances the sensitivity of glioblastoma to temozolomide
- Surface modified Mg-doped ZnO QDs for biological imaging
- Passive and specific targeting of lymph nodes: the influence of the administration route
- Short Communication
- Unleashing the power of comparative oncology models in nanomedicine research
Articles in the same Issue
- Frontmatter
- In this issue
- Guest Editorial
- Nanomedicines: are we lost in translation?
- Meeting Report
- Is the translational approach becoming a reality in nanomedicine?
- Review
- Designer peptide delivery systems for gene therapy
- Original Articles
- Combined silencing expression of MGMT with EGFR or galectin-1 enhances the sensitivity of glioblastoma to temozolomide
- Surface modified Mg-doped ZnO QDs for biological imaging
- Passive and specific targeting of lymph nodes: the influence of the administration route
- Short Communication
- Unleashing the power of comparative oncology models in nanomedicine research
